In 2023, Egypt's import of antibiotics stood at a certain figure, against which the forecasted values for 2024 onwards suggest a steady incremental trend. For the years 2024 to 2028, the imports are predicted to increase from $143.33 million to $147.48 million. This represents a consistent year-on-year growth, averaging around 0.9% to 1% annually.
Key observations:
- The year-on-year growth rate for 2024 to 2025 is approximately 0.74%.
- The year-on-year growth rate for 2025 to 2026 is around 0.73%.
- The years 2026 to 2027 and 2027 to 2028 see minor increases with rates of 0.7% each.
Over a five-year horizon, the compound annual growth rate (CAGR) averages out to approximately 0.85%. This showcases a steady but modest upward trajectory in the importation of antibiotics.
Future trends to watch for:
- Impact of global antibiotic supply chains and potential disruptions.
- Policy changes in Egypt regarding healthcare and import regulations.
- Shifts in domestic production capabilities and pharmaceutical innovations.
